mTOR deletion in neural crest cells disrupts cardiac outflow tract remodeling and causes a spectrum of cardiac defects through the mTORC1 pathway
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Developmental Biology
- Vol. 477, 241-250
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5K12DE023583-05)
- Columbia University
- College of Dental Medicine, Columbia University
This publication has 48 references indexed in Scilit:
- Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia SuppressionCell Stem Cell, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Neural crest stem cells: discovery, properties and potential for therapyCell Research, 2012
- Endoplasmic reticulum is a main localization site of mTORC2Biochemical and Biophysical Research Communications, 2011
- Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycinHuman Molecular Genetics, 2011
- Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and ActivityJournal of Biological Chemistry, 2010
- mTORC1 Links Protein Quality and Quantity Control by Sensing Chaperone AvailabilityJournal of Biological Chemistry, 2010
- Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathyJournal of Cell Biology, 2009
- Disruption of Smad4 in neural crest cells leads to mid-gestation death with pharyngeal arch, craniofacial and cardiac defectsDevelopmental Biology, 2008
- Model systems for the study of heart development and diseaseSeminars in Cell & Developmental Biology, 2007